Natural Killer Cell Therapy Market
Natural Killer Cell Therapy Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Natural Killer Cell Therapy Market Size and Growth
The global Natural Killer Cell Therapy market is expected to reach a value of $XXX million by 2025, growing at a CAGR of XX% during the forecast period. Factors driving market growth include increasing prevalence of cancer and autoimmune diseases, advancements in immunotherapy, and rising investments in research and development.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Nektar Therapeutics
◍ Innate Pharma SA
◍ Affimed
◍ Chipscreen Biosciences
◍ Glycostem Therapeutics
◍ Fate Therapeutics
◍ Dragonfly Therapeutics
◍ Kiadis Pharma
◍ Nkarta Therapeutics
◍ NantKwest
Competitive Landscape:
- Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest are key players in the Natural Killer Cell Therapy market.
- These companies use NK cell therapy for cancer treatment, infectious diseases, and autoimmune disorders to drive market growth.
Sales Revenue:
- Nektar Therapeutics: $1.08 billion in 2020
- Fate Therapeutics: $42.25 million in Q4 2020
- NantKwest: $4.4 million in Q4 2020
Request Sample Report
Market Segmentation
By Application
Cancer
Gastrointestinal Diseases
Others
Request Sample Report
By Product
NK Cell Therapies
NK Cell Directed Antibodies
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ 1207.10 Million
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients